Evidence map›Paper›PMID 39834339›Full record

ArticleGlobal health action2024

Social vulnerability index associated with higher COVID-19 seroprevalence in Nigeria.

Natalia Blanco, Olanrewaju Lawal, Jibreel Jumare, Christina Riley, James Onyemata, Thomas Kono, Anna Winters, Chenfeng Xiong, Alash'le Abimiku, Manhattan Charurat and 2 more

Abstract read
In one paragraph

Article in Global health action, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Natalia BlancoInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-3157-1119
Olanrewaju LawalDepartment of Geography and Environmental Management, Faculty of Social Sciences University of Port Harcourt, Port Harcourt, Nigeria.ORCID 0000-0001-6468-1982
Jibreel JumareInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Christina RileyAkros, Lusaka, Zambia.
James OnyemataInternational Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria.
Thomas KonoMinnesota Supercomputing Institute, University of Minnesota, Minneapolis, Minnesota, USA.
Anna WintersAkros, Lusaka, Zambia.
Chenfeng XiongDepartment of Civil and Environmental Engineering, College of Engineering, Villanova University, Villanova, PA, USA.
Alash'le AbimikuInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Manhattan CharuratInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Kristen A StaffordInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
INFORM Africa Research Study Group

Funding

Role of Data Streams In Informing Infection Dynamics in Africa- INFORM AfricaU54TW012041 · FIC · INSTITUTE OF HUMAN VIROLOGY · PI Alash'le G. Abimiku, Tulio de Paiva Nazareth Andrade De Oliveira · 2021 to 2026
$6.9M
FIC NIH HHS U54 TW012041
6 · The paper itself

Abstract

Social vulnerability has been shown to be a strong predictor of disparities in health outcomes. A common approach to estimating social vulnerability is using a composite index, such as the social vulnerability index (SVI), which combines multiple factors corresponding to key social determinants of health. Lawal and Osayomi created an SVI to explore key social determinants of health-related COVID-19 infection among the Nigerian population. This study explored the association of COVID-19 SVI with COVID-19 seroprevalence using a large household survey in Nigeria. Weighted COVID-19 seroprevalence estimates at the Local Government Areas (LGA) were estimated and merged with the Lawal and Osayomi SVI, also at the LGA-level. Linear regression models were constructed to evaluate the relationship between the SVI and COVID-19 seroprevalence. The effect of SVI was evaluated both as a continuous variable and categorized into quintiles to evaluate dose-response effects. Our results confirmed a positive relationship between social vulnerability and COVID-19 infection in four states and the Federal Capital Territory in Nigeria. Compared to class 1 (the least vulnerable group), COVID-19 seroprevalence was, on average, 9.21% and 6.42% higher in classes 4 and 5 LGAs, respectively, after adjustment by phase of the survey. The effect was particularly strong farther into the pandemic (June 2021), when COVID-19 mitigation measures were relaxed. In conclusion, SVI can potentially be a useful tool to effectively prioritize communities for resource allocation as part of emergency response and preparedness in Africa.

Indexed as

COVID-19Social VulnerabilityAdolescentAdultAgedFemaleHumansMaleMiddle AgedNigeriaSARS-CoV-2Seroepidemiologic StudiesSocial Determinants of HealthSocioeconomic FactorsVulnerable PopulationsYoung AdultCOVID-19Nigeriaseroprevalencesocial determinantsSocial vulnerability index

Identifiers

PMID39834339
PMCPMC11753008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.